Abstract:Triple-negative breast cancer (TNBC) represents approximately 20% of all breast cancers and appears resistance to conventional cytotoxic chemotherapy, demonstrating a particularly poor prognosis and a significantly worse clinical outcome than other types of cancer. Suicide gene therapy has been used for the in vivo treatment of various solid tumors in recent clinical trials. In tumor microenvironment, STAT3/NF-κB pathways are constitutively activated in stromal cells as well as in cancer stem cells (CSCs). In this study, we have cloned a novel STAT3/NF-κB-based reporter system to drive the expression of herpes simplex virus thymidine kinase (HSV-TK) against breast cancer. Lentiviral vector expressing HSV-TK under the regulation of STAT3/NF-κB fused response element was developed. In this setting, we exploited the constitutive STAT3/NF-κB activation in tumors to achieve higher transgene expression than that driven by a constitutively active CMV promotor in vivo. An orthotropic MDA-MB-231 triple negative breast cancer mouse model was used for evaluating the feasibility of STAT3-NF-κB-TK/GCV suicide gene therapy system. The basal promoter activity of Lenti-CMV-TK and Lenti-STAT3-NF-κB-TK in MDA-MB-231 cells was compared by 3H-FEAU uptake assay. The Lenti-CMV-TK showed ~5 fold higher 3H-FEAU uptake then Lenti -STAT3-NF-κB-TK. In clonogenic assay, cells expressing Lenti-CMV-TK were 2-fold more sensitive to GCV than Lenti-STAT3-NF-κB-TK transduced cells. In vitro effect of STAT3-NF-κB-induced transgene expression was determined by 10ng/mL TNF-α induction and confirmed by western blot analysis and DsRedm fluorescent microscopy. In vivo evaluation of therapeutic effect by bioluminescence and [18F]FHBG microPET imaging indicated that Lenti-STAT3-NF-κB-TK showed more tumor growth retardation than Lenti-CMV-TK when GCV (20 mg/kg) was administered. The invasiveness and expression of cancer stem cell markers were both decreased after STAT3/NF-κB-regulated HSV-TK/GCV therapy. Moreover, STAT3/NF-κB signaling targeting could further sensitize tumor cells to cisplatin. This study successfully established a theranositic approach to treat triple-negative breast cancer via STAT3-NF-κB responsive element-driven suicide gene therapy. This platform may also be an alternative strategy to handle with drug-resistant cancer cells.

Caspase-3-independent Pathways Proceeding in Bystander Effect of HSV- Tk /GCV System

Relationship Between the Expression of Connexin43 and Bystander Effect of Suicide Gene Therapy in Ovarian Cancer

Killing effect of mutant herpes simplex virus type 1 thymidine kinase on rat C6 glioma cells

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

HSV-TK/GCV System-Mediated Bystander Tumoricidal Effect on Bladder Cancer Cells

Rerovirus Mediated Hsv-Tk Gene Transfer Can Influence The Function Of Human T-Lymphocyte

[Experimental Studies on the Characteristics of Suicide Gene System HSV-tk/GCV and Its Effect on Dendritic Cells].

The Effects of HSV-TK/GCV Suicide Gene Therapy System on Human Pancreatic Cancer Cells

4:10 PM Abstract No. 50 Intratumoral Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene Therapy of Orthotopic Lung Cancer Through the Augmentation of Apoptosis and Heat Shock Protein (HSP70) Expression Pathway

[Experimental Study on Human Pulmonary Adenocarcinoma Cell A549 Transfected with HSV₁-TK Gene in Vitro and in Vivo].

Mechanisms of antitumor effects of herpes simplex virus-thymidine kinase suicide gene on nasopharyngeal carcinoma cells

Anti-hepatoma effect of suicide gene therapy using HSV/TK combined with ganciclovir in hepatoma cells

The Effect of Lentivirus-Mediated Suicide Gene Therapy on Lens Epithelial Cells

Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.

Targeting Genomic Rearrangements in Tumor Cells Through Cas9-mediated Insertion of a Suicide Gene

A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing

Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy for experimental prostate cancer

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Esophageal Squamous Cancers.

STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer

Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines]

[The Cell-Type-specific HSV-tk Gene Expression of Suicide Gene Therapy System Regulated by Lens-Specific Promoter LEP503].